Searched for
SUVEN PHARMACEUTICALS STOCKS
Ahead of Market: 10 things that will decide stock market action on TuesdayIndian indices were subdued with Nifty up 0.03% and Sensex down 0.10%. High volatility (VIX at 19.63) and bearish momentum indicators sugge...- I-Sec initiates coverage on Suven Pharmaceuticals with a Buy rating, target price Rs 1,400ICICI Securities recommends buying Suven Pharmaceuticals with a target price of Rs 1,400. The firm exhibits strong quarterly growth, report...
- National Company Law Tribunal clears Casper Pharma’s merger with Suven PharmaceuticalsThe NCLT Mumbai has approved the merger of Casper Pharma with Suven Pharmaceuticals. This merger aims to improve efficiency, reduce costs, ...
- Merger effect! Suven Pharma shares jump 15% in 2 daysAfter the merger becomes effective, all shareholders of Cohance will be issued shares of Suven at the ratio of 11 shares of Suven for every...
- Suven Pharmaceuticals shares soar 13% on proposed merger with Cohance LifesciencesShares of Suven Pharmaceuticals surged 13% on the NSE after proposing a merger with Cohance Lifesciences to strengthen its CDMO industry po...
- Suven Pharmaceuticals shares jump over 6% after cabinet approves Rs 9,589 crore FDIAccording to the latest shareholding pattern available with the exchanges, as of 30 June 2023, 60% of the company's shareholding is with th...
- Cabinet approves foreign investment of up to Rs 9,589 crore in Suven PharmaThe Cabinet Committee on Economic Affairs has approved foreign investment of up to Rs 9,589 crore in Suven Pharmaceuticals by Cyprus-based ...
- Buy Suven Pharmaceuticals, target price Rs 520: Nuvama Wealth brokerageBroken 3-month consolidation range on the higher side affirming a strong base formation at 470 levels.
- Advent International buys Suven Pharma for Rs 6,313 croreAdvent will also launch an open offer for an additional 26% of the company, a listed contract research and manufacturing services (CRAMS) b...
- Suven Pharma falls 2% as Advent picks majority stake in the companyPost the completion of this acquisition, Advent intends to explore the merger of its portfolio company, Cohance Lifesciences with Suven, to...
- Advent pips Blackstone, set to buy Suven Pharma for Rs 6300 crMarket capitalisation of Suven Pharma, as on Friday, was ₹12,682.43 crore. ET was the first to report on the sale on December 23. Advent is...
- Advent pips Blackstone, set to buy Suven Pharma for Rs 6300 crAnnouncement expected as early as Monday morning. Open offer if fully subscribed to could make it a $1 bn deal
- Advent closes in on Suven Pharma buyoutPromoters Venkateswarlu Jasti and his family split Suven Life Sciences in FY20, turning the CRAMS business into a separately listed company...
- Accumulate Suven Pharmaceuticals, target price Rs 602: Geojit Financial ServicesSuven Pharma’s total revenues grew 40% YoY to Rs.364 crore with the Formulations and CRAMS (pharma) reporting stellar growth this quarter o...
- Buy Suven Pharmaceuticals, target price Rs 627: Anand RathiSuven Pharmaceuticals Ltd., incorporated in the year 2018, is a Small Cap company (having a market cap of Rs 13147.01 Crore) operating in P...
- Buy Suven Pharmaceuticals, target price Rs 560: ICICI DirectSuven Pharmaceuticals Ltd., incorporated in the year 2018, is a Small Cap company (having a market cap of Rs 12075.29 Crore) operating in P...
- Buy Suven Life Sciences, target Rs 287: Jay ThakkarBuy Suven Life Sciences at a price target of Rs 287 and a stop loss at Rs 228.
- Suven Life Sciences manufacturing facility gets USFDA approvalSuven Life Sciences today said it has received the US health regulator''s approval for its active pharmaceutical ingredients.
- Suven starts phase I clinical trials of SUVN-502Pharmaceutical firm Suven Life Sciences today said it has commenced phase I clinical trials of SUVN-502, used in the treatment of Alzheimer...
- Suven ties up with US-based pharma coSuven Life Sciences Ltd has signed an agreement with US-based pharmaceutical firm Eli Lilly and Company to carryout pre-clinical research f...
Load More
